Reactions

Reactions

Reactions

When science hits the headlines, we seek the views of expert sources who assess the news rigorously and quickly, according to the available evidence.

Reaction to study showing efficacy of meningitis B vaccine in under-fives in Spain

Researchers have analysed the efficacy of the meningococcal serogroup B vaccine (4CMenB, Bexsero) in more than 1,500 children under five years of age in Spain. The research, published in the New England Journal of Medicine, shows that full vaccination was effective in preventing invasive meningococcal disease of both serogroup B and other serogroups in this child population. The vaccine, which had been sold privately in Spain since 2015, had already been included by several autonomous communities in their vaccination schedules. Last December, the Interterritorial Council of the National Health System (CISNS) approved its inclusion in the vaccination schedule for the whole of Spain.

0

Reactions to research linking beta-blocker treatment with lower rates of violence

Beta-blockers (β-blockers) are drugs to treat heart conditions that are also used for anxiety. According to research published in PLOS Medicine, periods of treatment with these drugs are associated with a lower risk of being charged by the police with a violent crime - a 13% lower risk than periods without treatment. The research, which included nearly 1.5 million people in Sweden between 2006 and 2013, does not support the use of these drugs to treat anxiety.

0

Reactions: pandemic caused educational delays equivalent to a third of the academic year

A meta-analysis of 42 studies from 15 countries, including Spain, concludes that the covid-19 pandemic caused learning delays in school-aged children and a loss of knowledge equivalent to 35% of the learning of a school year. The research, published in Nature Human Behaviour, highlights that these effects persisted over time.

0

Reactions to the evolution of suicide data in Spain between 2000 and 2021

The rate of death by suicide in Spain has increased between 2018 and 2021, according to a report presented today by the Complutense University of Madrid, the Centre for Biomedical Research in Mental Health Network (CIBERSAM) and the Hospital del Mar in Barcelona, which points to the influence of the pandemic in this increase. In 2021, a total of 4,003 people died from this cause, 5.5% more than in 2018. During the pandemic, mortality by suicide was greater among people living in large cities and provincial capitals. The report, which includes data from 2000 to 2021, also shows the increase in deaths by suicide that occurred during the period of the economic crisis, from 2008 to 2014.

0

Reactions: Academic outcomes of IVF-conceived girls and boys do not differ from those conceived naturally

A study published in the journal PLOS Medicine concludes that the development and academic outcomes of girls and boys conceived with in vitro fertilisation (IVF) are no different from those of children conceived naturally. The analysis is based on data from two national assessments in Australia, including more than 585,000 children born between 2005 and 2014 (more than 11,000 conceived by IVF). The first assessment measured the physical and emotional and cognitive health of children aged 4-6 years; the second focused on the numeracy and verbal skills of schoolchildren aged 7-9 years.

0

Reactions to study linking sleep deprivation in adolescence with increased risk of multiple sclerosis

A Swedish study has found an association between lack of sleep or poor quality sleep during adolescence and an increased risk of developing multiple sclerosis later in life. They put the relative increased risk at 40 %. The results are published in the Journal of Neurology, Neurosurgery and Psychiatry.

0

Reactions to trial using CAR-T cells prepared from donors to treat multiple myeloma

Approved therapies to treat various tumours using CAR-T cells are based on the modification of the patient's own lymphocytes in the laboratory, which delays their administration. A phase 1 clinical trial has used ready-made donor cells to treat patients with multiple myeloma. The results are published in the journal Nature Medicine.

0